Pfizer Inc (NYSE:PFE)

36.54
Delayed Data
As of Jan 22
 +0.06 / +0.16%
Today’s Change
26.43
Today|||52-Week Range
43.08
-0.73%
Year-to-Date
Why Pfizer's Future Looks Better in 2021
2:30pm / MotleyFool.com - Paid Partner Content
Is Johnson & Johnson a Buy?
Jan 21 / MotleyFool.com - Paid Partner Content
3 Reasons This Hot Stock May Not Survive 2021
10:30am / MotleyFool.com - Paid Partner Content
3 Reasons to Buy Novavax Stock, and 1 Reason to Sell
Jan 21 / MotleyFool.com - Paid Partner Content
3 Blockbuster Drug Launches to Watch This Year
8:53am / MotleyFool.com - Paid Partner Content
Better Coronavirus Stock: Novavax or Vaxart?
Jan 21 / MotleyFool.com - Paid Partner Content
BioNTech's Potential Winners Beyond Its COVID Vaccine
8:15am / MotleyFool.com - Paid Partner Content
3 COVID Stocks to Buy if You're Not a Big Risk-Taker
Jan 21 / MotleyFool.com - Paid Partner Content
What Kind of Deals Is Pfizer Planning for the Next Few Years?
6:10am / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know
Jan 20 / Zacks.com - Paid Partner Content
How Are COVID Vaccine Rollouts Going in Europe?
Jan 23 / MotleyFool.com - Paid Partner Content
Pfizer and BioNTech Report Evidence That Their Vaccine Is Effective Against COVID-19 Variant
Jan 20 / MotleyFool.com - Paid Partner Content
What Does 2021 Hold for BioNTech Stock?
Jan 23 / MotleyFool.com - Paid Partner Content
US Indexes Close Higher Wednesday
Jan 20 / GuruFocus News - Paid Partner Content
Here Are the Biggest Hurdles for COVID Vaccinations
Jan 23 / MotleyFool.com - Paid Partner Content
Moderna Investigating Reports of Allergic Reactions to Its Coronavirus Vaccine
Jan 20 / MotleyFool.com - Paid Partner Content
Could Moderna Be a Millionaire-Maker Stock?
Jan 23 / MotleyFool.com - Paid Partner Content
Gritstone (GRTS) to Begin Coronavirus Vaccine Study, Stock Up
Jan 20 / Zacks.com - Paid Partner Content
Is This Under-the-Radar COVID Stock the Next Moderna?
Jan 23 / MotleyFool.com - Paid Partner Content
My Best SaaS Stock for 2021
Jan 20 / MotleyFool.com - Paid Partner Content
Better Buy: Gilead Sciences vs. Pfizer
Jan 23 / MotleyFool.com - Paid Partner Content
Is It Too Late for Oil Stocks?
Jan 20 / MotleyFool.com - Paid Partner Content
Top Coronavirus Vaccine Makers Will Earn Up to $23 Billion in Revenue This Year, Says New Analysis
Jan 22 / MotleyFool.com - Paid Partner Content
Is Inovio Pharmaceuticals a Buy?
Jan 20 / MotleyFool.com - Paid Partner Content
VBI Vaccines (VBIV) Provides Updates on COVID-19 Vaccine
Jan 22 / Zacks.com - Paid Partner Content
2 High-Yield Dividend Stocks to Buy Now
Jan 20 / MotleyFool.com - Paid Partner Content
Q4 Earnings Season Scorecard and Analyst Reports for Amazon, JPMorgan & Pfizer
Jan 22 / Zacks.com - Paid Partner Content
Biohaven (BHVN) Falls as Troriluzole Fails in Alzheimer's Study
Jan 19 / Zacks.com - Paid Partner Content
What Investors Need to Know About Coronavirus Variants
Jan 22 / MotleyFool.com - Paid Partner Content
Stock Market News for Jan 19, 2021
Jan 19 / Zacks.com - Paid Partner Content
Moderna's (MRNA) Coronavirus Vaccine Study Begins in Japan
Jan 22 / Zacks.com - Paid Partner Content
Grifols (GRFS) to Begin Study on Plasma-Derived COVID-19 Drug
Jan 19 / Zacks.com - Paid Partner Content
More COVID Vaccines Should Become Available With This Major Strategy Change
Jan 22 / MotleyFool.com - Paid Partner Content
Where Will Pfizer Be in 5 Years?
Jan 19 / MotleyFool.com - Paid Partner Content
Bill Ackman Pushes 3 Retailers to Get Directly Involved in U.S. Coronavirus Vaccine Drive
Jan 22 / MotleyFool.com - Paid Partner Content
Wall Street Couldn't Stop Buying Shares of These 2 Stocks in 2020
Jan 19 / MotleyFool.com - Paid Partner Content
3 Cheap Dividend Aristocrats to Buy Right Now
Jan 22 / MotleyFool.com - Paid Partner Content
Stock Market News for Jan 18, 2021
Jan 18 / Zacks.com - Paid Partner Content
3 Warren Buffett Stocks That Should Be Surefire Winners in 2021
Jan 22 / MotleyFool.com - Paid Partner Content
Dr. Reddy's (RDY) to Begin Phase III Study on Sputnik Vaccine
Jan 18 / Zacks.com - Paid Partner Content
Pfizer and BioNTech to Supply WHO's COVID-19 Vaccine Program
Jan 21 / MotleyFool.com - Paid Partner Content
Should You Buy Johnson & Johnson For Its COVID Vaccine?
Jan 18 / MotleyFool.com - Paid Partner Content
United Airlines Suffering Losses Through the 4th Quarter
Jan 21 / GuruFocus News - Paid Partner Content
AstraZeneca (AZN) Gets EU Nod for Improved Imfinzi Dosing
Jan 18 / Zacks.com - Paid Partner Content
Gilead (GILD) Up 19% in the Past Month: What Lies Ahead?
Jan 21 / Zacks.com - Paid Partner Content
The Biggest Drug Competition in 2021 (Hint: It Isn't COVID Vaccines)
Jan 17 / MotleyFool.com - Paid Partner Content
Will Sarepta's (SRPT) Overdependence on Exondys 51 Hurt?
Jan 21 / Zacks.com - Paid Partner Content
This Is the Best News Yet for Moderna's COVID Vaccine
Jan 17 / MotleyFool.com - Paid Partner Content
Should You Get A Vaccine If You've Already Recovered From COVID?
Jan 21 / MotleyFool.com - Paid Partner Content
3 Popular Robinhood Stocks That Should Make You Richer in 2021
Jan 17 / MotleyFool.com - Paid Partner Content